Projects per year
Abstract
Antimicrobial resistance has emerged as a global public health threat, and development of novel therapeutics for treating infections caused by multi-drug resistant bacteria is urgent. Staphylococcus aureus is a major human and animal pathogen, responsible for high levels of morbidity and mortality worldwide. The intracellular survival of S. aureus in macrophages contributes to immune evasion, dissemination, and resilience to antibiotic treatment. Here, we present a confocal fluorescence imaging assay for monitoring macrophage infection by green fluorescent protein (GFP)-tagged S. aureus as a front-line tool to identify antibiotic leads. The assay was employed in combination with nanoscaled chemical analyses to facilitate the discovery of a new, active rifamycin analogue. Our findings indicate a promising new approach for the identification of antimicrobial compounds with macrophage intracellular activity. The antibiotic identified here may represent a useful addition to our armory in tackling the silent pandemic of antimicrobial resistance.
Original language | English |
---|---|
Pages (from-to) | 1499-1507 |
Journal | ACS infectious diseases |
Volume | 9 |
Issue number | 8 |
Early online date | 11 Jul 2023 |
DOIs | |
Publication status | Published - 11 Aug 2023 |
Keywords / Materials (for Non-textual outputs)
- Animals
- Anti-Bacterial Agents/pharmacology
- Green Fluorescent Proteins/genetics
- Humans
- Macrophages
- Rifamycins/therapeutic use
- Staphylococcal Infections/microbiology
- Staphylococcus aureus
Fingerprint
Dive into the research topics of 'Nanoscaled discovery of a shunt rifamycin from Salinispora arenicola using a three-colour GFP-tagged Staphylococcus aureus macrophage infection assay'. Together they form a unique fingerprint.Projects
- 1 Active